IRIS
FRIERI, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.195
EU - Europa 2.508
AS - Asia 2.420
SA - Sud America 257
AF - Africa 18
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 9.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.141
SG - Singapore 958
IE - Irlanda 580
CN - Cina 563
RU - Federazione Russa 482
SE - Svezia 310
TR - Turchia 281
HK - Hong Kong 247
DE - Germania 240
VN - Vietnam 225
BR - Brasile 222
IT - Italia 204
GB - Regno Unito 194
UA - Ucraina 163
FR - Francia 126
FI - Finlandia 97
IN - India 33
CA - Canada 30
JP - Giappone 28
BE - Belgio 21
CZ - Repubblica Ceca 20
AR - Argentina 19
MX - Messico 17
NL - Olanda 17
PL - Polonia 16
BD - Bangladesh 15
ES - Italia 14
IQ - Iraq 12
ID - Indonesia 11
AU - Australia 6
EU - Europa 6
UZ - Uzbekistan 6
EC - Ecuador 5
LT - Lituania 5
ZA - Sudafrica 5
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
EE - Estonia 3
IL - Israele 3
JO - Giordania 3
KR - Corea 3
KW - Kuwait 3
LU - Lussemburgo 3
MA - Marocco 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CG - Congo 2
GE - Georgia 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
NP - Nepal 2
PY - Paraguay 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
SC - Seychelles 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 9.412
Salva come PNG Salva come JPEG
Città #
Jacksonville 646
Chandler 614
Dublin 580
Singapore 575
San Jose 369
Dallas 268
Hong Kong 246
Ashburn 210
Boardman 191
Santa Clara 189
Izmir 135
Nanjing 135
New York 113
Ann Arbor 110
San Mateo 108
The Dalles 86
Lawrence 85
Beijing 84
Princeton 84
Moscow 80
Ho Chi Minh City 78
Wilmington 72
Lauterbourg 54
Hanoi 52
Milan 42
Los Angeles 39
Woodbridge 39
Council Bluffs 33
L'aquila 33
Dearborn 31
Nanchang 31
Hefei 28
São Paulo 28
Munich 27
Des Moines 25
Verona 24
Shenyang 23
Tokyo 23
Shanghai 22
Brussels 21
Kunming 21
Seattle 21
Tianjin 21
Bremen 20
Orem 19
Hebei 18
Brno 17
Jiaxing 17
London 17
Jinan 16
Warsaw 16
Frankfurt am Main 15
Norwalk 15
Rome 14
Turku 14
Mountain View 13
Stockholm 13
Columbus 12
Dong Ket 12
Helsinki 12
L’Aquila 12
Boston 11
Changsha 11
Ningbo 11
Amsterdam 10
Chennai 10
Montreal 10
Poplar 10
Da Nang 9
Hangzhou 9
Mexico City 9
Brooklyn 8
Auburn Hills 7
Brasília 7
Manchester 7
Rio de Janeiro 7
Ankara 6
Chicago 6
Falls Church 6
Florence 6
Phoenix 6
San Francisco 6
Tappahannock 6
Zhengzhou 6
Berlin 5
Dhaka 5
Falkenstein 5
Guangzhou 5
Haiphong 5
Hải Dương 5
Jakarta 5
Sydney 5
Taizhou 5
Tashkent 5
Baghdad 4
Biên Hòa 4
Changchun 4
Denver 4
Houston 4
Istanbul 4
Totale 6.226
Salva come PNG Salva come JPEG
Nome #
Association between vasomotor rhinitis and irritable bowel syndrome. 228
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 177
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 163
Histological healing in ulcerative colitis with mesalazine and its prognostic role 159
IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature 156
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 153
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 151
Association between colonic diverticula and colorectal polyps and cancer 149
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 149
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 146
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 145
Association between colorectal polyps and colonic diverticulosis 142
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 140
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 138
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 131
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 129
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 129
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 129
GI distension in severe ulcerative colitis 125
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 125
Il 5-ASA (Asacol) previene le recidive post-operatorie del morbo di Crohn. Risultati dello studio GISC a tre anni di follow-up. 124
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 121
Ulcerative Colitis: rectal dilations in a patient with refractory diarrhoea. Report of a case 119
Mucosal healing: Mayo 0 vs 1 after 3 years. 119
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 119
Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-β1 downregulation 118
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 118
Duodenal lymphocytosis in functional dyspepsia 117
Celiac disease, gluten-free diet, and metabolic and liver disorders 117
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats 116
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 114
Electrolyte and acid base imbalance in patients with rectosigmoid bladder. 114
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 111
Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity 111
Is mesalazine treatment effective in the prevention of diverticulitis? A review 110
n-Butyrate Rectal Transport in Cirrhotic Patients 110
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients 109
Early acid perception in NERD 109
Colonoscopic control of uretero-enteric anastomoses in internal urinary diversion. 107
Colonic electromyography in chronic constipation. 107
Carbonic andhydrase I reduction in colonic mucosa of patients with active ulcerative colitis 107
Incidence of inflammatory Bowel disease in Italy: A nationwide population-based study 106
The role on endoscopy in alcohol-related diseases 106
Short-chain fatty acids topical treatment in distal ulcerative colitis 105
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 105
Prognostic factors for post-operative recurrence of Crohn's disease 105
Acute colitis following colonoscopy 104
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010 104
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 104
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease 104
Assesment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhancement MRI 102
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 102
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis. 102
Dextran sulfate sodium (DSS) colitis in rats. Clinical, structural, and ultrastructual aspects 101
Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled Pilot Study 99
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine 99
Abnormalities of colonic mucin secretion and metabolic changes after internal urinary diversion for bladder extrophy. A prospective study. 96
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 95
Multiple organ dysfunction in ulcerative colitis 95
Management of colonic diverticular disease. 95
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 95
An unusual treatment for a colonic polyp. 94
Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet. 94
Abnormal Patterns of Colorectal Mucin Secretion after Urinary Diversion of Different Types: Histochemical and Lectin Binding Studies 93
Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic biopsy samples in humans by high-performance liquid chromatography with electrochemical detection 93
Report of the 3rd National Congress of the Italian Federation of Coloproctology. 93
Abnormal Patterns of Colonic Mucin Secretion after Ureterosigmoidostomy 92
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis 92
Current opinions on treatment of inflammatory bowel disease 91
Consequence of colonic involvement on electrolyte and acid-base homeostasis in crohn's disease 91
Mucosal 5-ASA concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis 90
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's Patients 88
CROHN’S DISEASE ACTIVITY INDEX IS INACCURATE TO DETECT THE POSTOPERATIVE RECURRENVCE IN CROHN’S DISEASE 88
Gastrointestinal: Eosinophilic ascites. 88
The long journey of salicylates in ulcerative colitis: The past and the future. 87
Italian consensus guidelines for chronic pancreatitis. 87
Risk factors in toxic megacolon 84
Historical evolution of the management of severe ulcerative colitis 83
Mesalazine vanishing time from rectal mucosa following its topical administration. 83
Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick? 82
Meccanismi e approccio alla fisiopatologia della diarrea. 80
Faecal excretion of bicarbonate in ulcerative colitis 79
Fattori di rischio per la recidiva post-operatoria nel morbo di Crohn. 74
The dyspeptic macrophage 30 years later. An update in the pathogenesis of Crohn's disease 73
Genetic analysis in italian families with inflammatory bowel disease supports linkage to the IBD1 locus-a GISC study 72
Thecnical performance of colonoscopy: thekey role of sedation/analgesia and other quality indicators 59
Totale 9.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021231 0 0 0 0 0 0 0 0 0 36 151 44
2021/2022566 37 49 129 44 23 4 10 31 25 28 37 149
2022/20231.714 116 97 30 197 152 186 0 116 740 7 47 26
2023/2024390 56 22 17 60 27 112 21 18 0 9 5 43
2024/20251.495 18 25 145 36 150 130 228 163 344 70 104 82
2025/20262.751 125 260 176 383 320 235 587 114 236 315 0 0
Totale 9.515